LBT Innovations Ltd. | Cash Flow

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
331.00
549.00
3,541.00
5,213.00
2,683.00
Depreciation, Depletion & Amortization
717.00
764.00
774.00
759.00
53.00
Other Funds
26.00
-
-
-
-
Funds from Operations
952.00
2,045.00
6,493.00
5,296.00
2,226.00
Changes in Working Capital
381.00
1,003.00
1,381.00
5,953.00
3,551.00
Net Operating Cash Flow
571.00
3,048.00
7,874.00
657.00
1,325.00
Capital Expenditures
74.00
5,459.00
3,822.00
4,670.00
2,556.00
Sale of Fixed Assets & Businesses
37.00
-
-
-
-
Purchase/Sale of Investments
-
-
84.00
2,805.00
4,451.00
Net Investing Cash Flow
37.00
5,459.00
3,906.00
7,475.00
7,007.00
Issuance/Reduction of Debt, Net
-
970.00
1,000.00
-
-
Net Financing Cash Flow
390.00
2,414.00
1,002.00
6,949.00
9,756.00
Net Change in Cash
915.00
27.00
2,864.00
1,184.00
4,074.00
Free Cash Flow
497.00
3,013.00
7,852.00
700.00
1,257.00
Deferred Taxes & Investment Tax Credit
1,737.00
924.00
1,667.00
434.00
84.00
Change in Capital Stock
416.00
1,444.00
2.00
6,949.00
9,756.00
Exchange Rate Effect
9.00
24.00
102.00
1.00
-

About LBT Innovations

View Profile
Address
44 Waymouth Street
Adelaide South Australia (SA) 5000
Australia
Employees -
Website http://www.lbtinnovations.com
Updated 07/08/2019
LBT Innovations Ltd. is an Australian developer of clinical and diagnostic technology, which has emerged as a groundbreaking designer of advanced automated solutions for the preparation and analysis of microbiology culture specimens, with significant benefits for busy clinical laboratories. The firm operates its business through research and development segments. The company was founded by Lusia Halina Guthrie, Douglas Peter LeMessurier and Paul Andrew Mariani in 2004 and is headquartered in Adelaide, Australia.